BioInvent International Balance Sheet Health
Financial Health criteria checks 5/6
BioInvent International has a total shareholder equity of SEK1.7B and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK1.8B and SEK70.8M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 1.22b |
| Equity | SEK 1.68b |
| Total liabilities | SEK 70.84m |
| Total assets | SEK 1.76b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BINVS's short term assets (SEK1.3B) exceed its short term liabilities (SEK53.8M).
Long Term Liabilities: BINVS's short term assets (SEK1.3B) exceed its long term liabilities (SEK17.1M).
Debt to Equity History and Analysis
Debt Level: BINVS is debt free.
Reducing Debt: BINVS has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BINVS has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if BINVS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.